Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Assets (Quarterly): 667.89M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 667.89M |
| June 30, 2024 | 660.75M |
| March 31, 2024 | 651.96M |
| December 31, 2023 | 646.62M |
| September 30, 2023 | 650.64M |
| June 30, 2023 | 443.59M |
| March 31, 2023 | 333.53M |
| December 31, 2022 | 352.91M |
| September 30, 2022 | 364.35M |
| June 30, 2022 | 297.23M |
| March 31, 2022 | 278.15M |
| December 31, 2021 | 294.65M |
| Date | Value |
|---|---|
| September 30, 2021 | 235.17M |
| June 30, 2021 | 247.67M |
| March 31, 2021 | 222.24M |
| December 31, 2020 | 240.86M |
| September 30, 2020 | 141.86M |
| June 30, 2020 | 155.77M |
| March 31, 2020 | 172.80M |
| December 31, 2019 | 146.71M |
| September 30, 2019 | 158.27M |
| June 30, 2019 | 104.27M |
| March 31, 2019 | 51.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
141.86M
Minimum
Sep 2020
667.89M
Maximum
Sep 2024
360.27M
Average
295.94M
Median
Total Assets (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | 437.35M |
| Cytokinetics Inc | 1.436B |
| Amicus Therapeutics Inc | 786.56M |
| MannKind Corp | 464.20M |
| TG Therapeutics Inc | 586.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 435.87M |
| Shareholders Equity (Quarterly) | 232.02M |
| Debt to Equity Ratio | 1.326 |
| Current Ratio | 3.340 |
| Net Debt Paydown Yield | -0.02% |